Results 151 to 160 of about 14,209 (224)

Quantifying evolutionary constraints on B cell affinity maturation

, 2014
The antibody repertoire of each individual is continuously updated by the evolutionary process of B cell receptor mutation and selection. It has recently become possible to gain detailed information concerning this process through high-throughput ...
Bedford, Trevor, Bradley, Philip, Matsen IV, Frederick A., McCoy, Connor O., Minin, Vladimir N., Robins, Harlan   +5 more
core   +2 more sources

Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications. [PDF]

Exp Hematol Oncol, 2021
Xu L, Su Y.
europepmc   +1 more source

Immunoglobulin light chain amyloidosis involved multiple organs [PDF]

QJM: An International Journal of Medicine, 2019
Jianjun Qiao, Juan Bai, Hong Fang
openaire   +3 more sources

Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives

Journal of Blood Medicine, 2019
Shayna Sarosiek, Vaishali Sanchorawala Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USACorrespondence: Shayna Sarosiek; Vaishali SanchorawalaAmyloidosis Center, Boston University School of Medicine and ...
Sarosiek S, Sanchorawala V
doaj  

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

, 2023
Danai Dima, Fauzia Ullah, Serhan Ünlü, Diana Basali, Mahir Khan, Md. Abdullah Saeed Khan, Xuefei Jia, Majid Jaberi‐Douraki, Beth Faiman, Sandra Mazzoni, Louis Williams, Christy Samaras, Jason Valent, Faiz Anwer, Jack Khouri, Shahzad Raza   +15 more
openalex   +1 more source

Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type [PDF]

, 2017
Background. Renal amyloidosis results from protein misfolding and leads to progressive renal insufficiency. Few data are available concerning the relevance of the histomorphological patterns and the dynamics of the disease process. Methods.
Hopfer, Helmut, Mihatsch, Michael J., Wiech, Thorsten   +2 more
core  

Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study. [PDF]

Sci Rep, 2022
Palmer C, Truong VT, Slivnick JA, Wolking S, Coleman P, Mazur W, Zareba KM.   +6 more
europepmc   +1 more source

A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis

, 2015
María Teresa Cibeira, Albert Oriol, Juan José Lahuerta, María‐Victoria Mateos, Javier de la Rubia, Miguel‐Teodoro Hernández, Miquel Granell, Carlos Fernández de Larrea, Jesús F. San Miguel, Joan Bladé   +9 more
openalex   +1 more source

Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group. [PDF]

Circ Heart Fail, 2022
Maurer MS, Dunnmon P, Fontana M, Quarta CC, Prasad K, Witteles RM, Rapezzi C, Signorovitch J, Lousada I, Merlini G.   +9 more
europepmc   +1 more source

Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis

, 2019
Surbhi Sidana, Surendra Dasari, Taxiarchis Kourelis, Angela Dispenzieri, David Murray, Rebecca L. King, Ellen D. McPhail, Marina Ramı́rez-Alvarado, Shaji Kumar, Morie A. Gertz   +9 more
openalex   +1 more source